Serena Williams Back in Testing Pool, But Maintains Retirement
Serenaโข Williams, 44, has re-entered the International Tennis โคIntegrity Agency’s (ITIA) International registered โtesting Pool as of October 6th, according to an updated list. The ITIA confirmed Williams notified them of herโฃ desire to be reinstated,making her subject to the agency’s “whereabouts” rules – requiring players to provide their location for potential random drug testing and remain accessible for an hour each day.
Though, Williams swiftly denied any plansโฃ for a โcompetitive return to tennis. In a post on X (formerly Twitter), โขshe stated, “Omg yall I’m NOT coming โback. โThis wildfire is crazy-.”
The testing โฃpool primarily includes the top 100 men’s and women’s singlesโค players,elite doubles and wheelchair players,and those seeking to return after a prolonged absence from competition. Re-entry intoโ the pool requires six months of compliance before tournament eligibility.
Officialsโ from the WTA Tour and the United States Tennis Association, speaking anonymously, โexpressedโค unawareness of Williams’ re-entry. While reinstatement inโค October would allow her to compete again from April 2026,speculation has centered on a potential return to the U.S. open mixed doubles tournament, which nowโข features wild-card pairings. Williams โขboasts a decoratedโฃ doubles career, โincluding 14 Grand Slam titles and three Olympic gold medalsโฃ alongside โขher sister, Venus, who continues toโ compete.
Despite the possibility of a return to singles, given Williams’ competitive history, she has not indicated anyโข such intention. Her sister, Venus, 45, demonstrated โher continued singles capability last year with a victory over Peyton Stearns at the Citi open. A return would also open the door for a potential appearance at Wimbledon,โ a tournament Williams โwon seven times.
In the past year,Williams has become a brand ambassador for telehealth โcompany Ro,which sells GLP-1 weight-loss medications,and her husband,Alexis Ohanian,is an investor and board member of the company. Williams has publicly discussed her personal useโ of these medications and her past struggles with body image duringโ her career, noting theโข contrast between her physique and the traditionally lean build of other athletes.
Currently, GLP-1 medications are not โprohibited by the World Anti-Doping Agency (WADA), โthough the association is actively monitoring and โstudying their potential impact on athletic performance.